Denali Therapeutics

Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
BioSpace
Wed, 04/2/25 - 11:35 am
Denali Therapeutics
Hunter Syndrome
blood-brain barrier
Denali's ALS drug fails to redeem itself, missing key biomarker in trial extension
Fierce Biotech
Thu, 03/6/25 - 11:04 am
Denali Therapeutics
ALS
clinical trials
DNL343
Denali eyes approval after Hunter syndrome drug clears safety measures, reduces biomarkers in open-label study
Fierce Biotech
Fri, 02/7/25 - 11:40 am
Denali Therapeutics
Hunter Syndrome
tividenofusp alfa
Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Fierce Biotech
Wed, 01/8/25 - 11:36 am
Tenvie Therapeutics
Denali Therapeutics
neurological disorders
ALS drugs from Denali, Calico come up short, marking more failures for Healey trial
BioPharma Dive
Tue, 01/7/25 - 11:42 am
Denali Therapeutics
AbbVie
Calico Life Sciences
ALS
clinical trials
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Stock Titan
Mon, 01/6/25 - 06:50 pm
Denali Therapeutics
clinical trials
ALS
DNL343
Denali Secures $500M in Financing, Focuses on Large Molecule Biotherapeutics
BioSpace
Tue, 02/27/24 - 11:19 pm
Denali Therapeutics
R&D
large molecule drugs
funding
Denali-Sanofi's ALS drug fails to meet mid-stage trial goal
Reuters
Fri, 02/16/24 - 11:36 am
Denali Therapeutics
Sanofi
ALS
clinical trials
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst
Benzinga
Sun, 09/10/23 - 08:00 pm
Denali Therapeutics
drug deliver
blood-brain barrier
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Fierce Biotech
Wed, 08/9/23 - 11:56 am
Takeda
Denali Therapeutics
Alzheimer's disease
clinical trials
Biogen buys into Denali’s amyloid beta program
Pharmaphorum
Thu, 04/13/23 - 10:05 am
Biogen
Denali Therapeutics
Alzheimer's disease
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
Motley Fool
Wed, 11/2/22 - 10:51 pm
Denali Therapeutics
clinical trials
Alzheimer's disease
TAK-594
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Mon, 10/3/22 - 11:28 pm
Biogen
Denali Therapeutics
Parkinson's Disease
clinical trials
BIIB122
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2022
BioSpace
Wed, 08/31/22 - 10:19 pm
Denali Therapeutics
clinical trials
DNL310
Hunter Syndrome
Denali Receives Formal Letter Regarding FDA Hold On Alzheimer's Potential Program
Benzinga
Mon, 02/14/22 - 11:00 am
Denali Therapeutics
FDA
DNL919
clinical hold
Alzheimer's disease
FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic
Fierce Biotech
Thu, 01/13/22 - 10:19 pm
Denali Therapeutics
Takeda
Alzheimer's disease
FDA
DNL919
Denali Moving Forward with Sanofi-Partnered ALS Candidate
BioSpace
Thu, 10/7/21 - 12:17 pm
Denali Therapeutics
Sanofi
ALS
DNL343
clinical trials
Denali Therapeutics Sees Positive Data in Trial for Enzyme Replacement Therapy
Marketwatch
Mon, 07/26/21 - 09:42 am
Denali Therapeutics
DNL310
enzymes
Hunter Syndrome
clinical trials
Biden's Budget May Boost These 3 Biotechs
Motley Fool
Mon, 05/10/21 - 09:31 pm
Joe Biden
Alzheimer's disease
Denali Therapeutics
Cassava Sciences
Eli Lilly

Pages